| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/09/2023 | 42.35% | Telsey Advisory Group | → $4 | Reiterates | Market Perform → Market Perform |
| 07/25/2023 | 184.7% | Stephens & Co. | → $8 | Reiterates | Overweight → Overweight |
| 07/25/2023 | 6.76% | Wells Fargo | $4 → $3 | Maintains | Equal-Weight |
| 07/25/2023 | 42.35% | Telsey Advisory Group | $5 → $4 | Downgrades | Outperform → Market Perform |
| 07/25/2023 | 6.76% | Goldman Sachs | $5 → $3 | Downgrades | Buy → Neutral |
| 05/10/2023 | 77.94% | Telsey Advisory Group | → $5 | Reiterates | → Outperform |
| 05/03/2023 | 77.94% | Telsey Advisory Group | → $5 | Reiterates | → Outperform |
| 03/01/2023 | 77.94% | Telsey Advisory Group | $5.5 → $5 | Maintains | Outperform |
| 02/23/2023 | 95.73% | Telsey Advisory Group | → $5.5 | Reiterates | → Outperform |
| 11/11/2022 | 184.7% | Stephens & Co. | $10 → $8 | Maintains | Overweight |
| 11/11/2022 | 24.56% | Morgan Stanley | $3.75 → $3.5 | Maintains | Equal-Weight |
| 11/11/2022 | 42.35% | Wells Fargo | $4.5 → $4 | Maintains | Equal-Weight |
| 11/11/2022 | 95.73% | Telsey Advisory Group | $6 → $5.5 | Maintains | Outperform |
| 10/04/2022 | 33.45% | Morgan Stanley | $3.5 → $3.75 | Maintains | Equal-Weight |
| 10/03/2022 | 60.14% | Wells Fargo | $3.5 → $4.5 | Maintains | Equal-Weight |
| 08/15/2022 | 24.56% | Morgan Stanley | $3.25 → $3.5 | Maintains | Equal-Weight |
| 05/13/2022 | 15.66% | Morgan Stanley | $8.15 → $3.25 | Maintains | Equal-Weight |
| 05/13/2022 | 113.52% | Telsey Advisory Group | $8 → $6 | Maintains | Outperform |
| 05/09/2022 | 184.7% | Telsey Advisory Group | $11 → $8 | Maintains | Outperform |
| 04/04/2022 | 469.4% | Goldman Sachs | $18 → $16 | Maintains | Buy |
| 02/25/2022 | 255.87% | Telsey Advisory Group | $14 → $10 | Maintains | Outperform |
| 11/15/2021 | 291.46% | Wells Fargo | → $11 | Downgrades | Overweight → Equal-Weight |
| 11/15/2021 | 398.22% | Telsey Advisory Group | $15 → $14 | Maintains | Outperform |
| 10/18/2021 | 469.4% | Loop Capital | → $16 | Initiates Coverage On | → Buy |
| 09/30/2021 | 433.81% | Telsey Advisory Group | → $15 | Initiates Coverage On | → Outperform |
| 08/16/2021 | 398.22% | B of A Securities | → $14 | Initiates Coverage On | → Neutral |
| 08/16/2021 | 576.16% | Stephens & Co. | → $19 | Initiates Coverage On | → Overweight |
| 08/16/2021 | 469.4% | Wells Fargo | → $16 | Initiates Coverage On | → Overweight |
| 08/16/2021 | 754.09% | BMO Capital | → $24 | Initiates Coverage On | → Outperform |
| 08/16/2021 | 896.44% | Goldman Sachs | → $28 | Initiates Coverage On | → Buy |
| 08/16/2021 | 416.01% | Morgan Stanley | → $14.5 | Initiates Coverage On | → Equal-Weight |
What is the target price for Zevia (ZVIA)?
The latest price target for Zevia (NYSE: ZVIA) was reported by Telsey Advisory Group on August 9, 2023. The analyst firm set a price target for $4.00 expecting ZVIA to rise to within 12 months (a possible 42.35% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Zevia (ZVIA)?
The latest analyst rating for Zevia (NYSE: ZVIA) was provided by Telsey Advisory Group, and Zevia reiterated their market perform rating.
When is the next analyst rating going to be posted or updated for Zevia (ZVIA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zevia, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zevia was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.
Is the Analyst Rating Zevia (ZVIA) correct?
While ratings are subjective and will change, the latest Zevia (ZVIA) rating was a reiterated with a price target of $0.00 to $4.00. The current price Zevia (ZVIA) is trading at is $2.81, which is within the analyst's predicted range.